Immunoglobulin for myasthenia gravis

Muayad A. Alzuabi, Apostolos Manolopoulos, Amjad Elmashala, Roupen Odabashian, Elie Naddaf, M. Hassan Murad

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of immunoglobulin in adults and children with acute exacerbation or worsening of myasthenia gravis (MG), or with chronic stable generalized MG. Specifically, we will investigate: 1) intravenous immunoglobulin (IVIg) compared to subcutaneous immunoglobulin (SCIg), and 2) immunoglobulin administered via either route (irrespective of treatment duration, dosage, and regimen) compared to no treatment, placebo, acetylcholinesterase inhibitors, plasma exchange, corticosteroids, or other immunosuppressive therapy.

Original languageEnglish (US)
Article numberCD013801
JournalCochrane Database of Systematic Reviews
Volume2020
Issue number12
DOIs
StatePublished - Dec 5 2020

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Immunoglobulin for myasthenia gravis'. Together they form a unique fingerprint.

Cite this